September 4th, 2024 (Shanghai) — We are glad to announce that Luis Martin, the Chief Executive Officer of CancerAppy, will be presenting at the ACCESS CHINA Partnering Forum – Autumn Virtual Showcase during September 24th to 25th, and 27th, 2024. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the western biopharma industry.
About CancerAppy
As a biotech company focused on cancer drug discovery and development, our AI technology allows us to identify promising new treatments and bring them closer to clinical use. By addressing unmet needs in cancer care, we aim to create effective new drugs, reduce the risk of failure in development, and ensure these treatments reach patients with fewer side effects and greater effectiveness.
With more than 20 years of research in cancer, our scientific team provides the knowledge and expertise to develop a robust and expanding pipeline of novel cancer therapeutics, featuring first-in-class agents. Our most advanced project is an ADC for pancreatic cancer with no competition targeting the same pathway. The proof of concept (PoC) has been completed, demonstrating that after 21 days of treatment, tumors in the control group tripled in size, while those treated with the ADC experienced complete remission. Additionally, we are developing a TEAD inhibitor, a PARP inhibitor, a PROTAC for breast cancer, and another potential ADC.
About the speaker
Global MBA with over 15 years of experience as a serial entrepreneur and technology/data science executive. Adept at initiating projects from inception and successfully bringing them to market.
Over the past four years, he expanded his international management experience, working across multiple regions including Europe, North America, and China. He skillfully implemented and enhanced his knowledge in AI for business, contributing to cutting-edge solutions.
In 2019, Luis founded Cancerappy and took on the role of CEO, successfully bringing 4 potential cancer drug programs to the preclinical phase and growing it into a global company.
Of note is his vast experience in managing technology startups and a strong track record in successfully bringing innovative software products to market. He is the founder of TatemonoProject, a cutting-edge publishing house, and co-founder of EstudioNOTE, an innovative creative studio. Additionally, he co-founded NAT Innovation Office, demonstrating his commitment to fostering cutting-edge advancements. Throughout his career, Luis has consistently demonstrated a deep ability to deliver comprehensive business insight and strategic vision.
About ACCESS CHINA Partnering Forum
ACCESS CHINA Partnering Forum – Autumn Virtual Showcase is scheduled to be held on September 24th to 25th, and 27th, 2024, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, audience can have access to innovative pharma and healthcare products from worldwide.
Conference Name: ACCESS CHINA Partnering Forum
Date & Time: Sep 24 – 25 (live), and 27 (VoD) 2024, China time
Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception
Scale: Expected 500+ participants Online; 100 company roadshows
Participants: Pharma/Biotech senior management and BDs
View more information at https://biotochina.org/
REGISTER
To Register for ACCESS CHINA online, please visit: ACCESS CHINA Biotech Forum
For more information, please contact:
Wendi Xiang
Wxiang@yafocapital.com
BioToChina.org 